Pilot Award 2026

Pilot Award 2026

Funder: The Lymphatic Malformation Institute (LMI)

Status: Active; 2026 cycle open

Award Amount: Maximum of $75,000 may be requested

Support Period: Up to 1 year of support is available

Geographic Scope: International applicants can apply

Focus Areas: Pilot awards are intended to test new hypotheses or technologies that have the potential to significantly advance understanding and/or treatment of CCLA, GLA, GSD, or KLA. Areas of interest include, but are not limited to:

Genetic analysis

Biomarker identification

Preclinical model development and characterization

Imaging

Single-cell RNA sequencing of animal or patient samples

Eligibility: Assistant professor or higher rank

Requirements: Preliminary data are required

Funder Model: LMI employs a unique, interactive model with in-house scientific team coordination. All submitted materials remain confidential with no external advisors involved. The institute maintains close communication with applicants and grantees for brainstorming and shaping project ideas.

Funder Status: LMI is a 501(c)(3) charitable organization. Federal ID#: 27-4299011

Contact: Michael Dellinger at michael.dellinger@utsouthwestern.edu